Back to Trades
Sethuraman Natarajan
PresidentResearch & Develop.CIK 0001873394
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 3
- Buy transactions
- 0
- Sell transactions
- 1
- Companies
- 1
- Active
- 2025–2026
Sethuraman Natarajan, President, Research & Develop., has filed 3 SEC reports (2025–2026), all concentrated in Entrada Therapeutics, Inc. (TRDA), totaling $1.5M in disclosed volume. Weighing $0 bought versus $398.8K sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
3 loaded
| May 4 | TRDA Entrada Therapeutics, Inc. | Sethuraman Natarajan | President, Research & Develop. | Sell | $398.8K |
| Mar 3 | TRDA Entrada Therapeutics, Inc. | Sethuraman Natarajan | President, Research & Develop. | Grant | $1.1M |
| Sep 4 | TRDA Entrada Therapeutics, Inc. | Sethuraman Natarajan | President, Research & Develop. | Tax withheld | $9.6K |
3 filings